309962-67-2 Usage
General Description
(R)-3-N-Boc-3-(methylamino)piperidine is a chemical compound that belongs to the class of piperidine derivatives. It is characterized by the presence of a tertiary amine group and a Boc (tert-butoxycarbonyl) protective group on the nitrogen atom. The molecule possesses a chiral center, and the (R)-stereoisomer refers to the configuration of the molecule. (R)-3-N-Boc-3-(methylamino)piperidine has potential applications in organic synthesis, particularly in the preparation of pharmaceutical intermediates and ligands for asymmetric catalysis. The Boc protective group provides stability to the amine functionality, making it a valuable building block for the synthesis of various nitrogen-containing compounds. Additionally, the presence of the methylamino group adds functionality and versatility to the molecule, making it useful in a range of chemical transformations.
Check Digit Verification of cas no
The CAS Registry Mumber 309962-67-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,0,9,9,6 and 2 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 309962-67:
(8*3)+(7*0)+(6*9)+(5*9)+(4*6)+(3*2)+(2*6)+(1*7)=172
172 % 10 = 2
So 309962-67-2 is a valid CAS Registry Number.
InChI:InChI=1/C11H22N2O2/c1-11(2,3)15-10(14)13(4)9-6-5-7-12-8-9/h9,12H,5-8H2,1-4H3/t9-/m1/s1
309962-67-2Relevant articles and documents
PYRROLOPYRIDINES AS KINASE INHIBITORS
-
, (2009/12/23)
Compounds of Formula (I) are useful for inhibition of CHKl and/or CHK2. Methods of using compounds of Formula (I) and stereoisomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.
Heterocyclic substituted aminoazacycles useful as central nervous system agents
-
Page 46, (2010/02/07)
Heterocyclic substituted aminoazacyclic compounds of the formula (I):Z-R3, wherein Z is a defined aminoazacycle and R3 is a defined heterocycle moiety, pharmaceutical compositions of these compounds, and use of said compositions to control synaptic transmission in mammals.